• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

空腹血糖和心肌血流储备对长期预后的影响超过其他危险因素和心脏病表型。

Long-term prognostic impact of fasting plasma glucose and myocardial flow reserve beyond other risk factors and heart disease phenotypes.

作者信息

Filidei Elena, Caselli Chiara, Menichetti Luca, Poli Michela, Petroni Debora, Guiducci Letizia, Sorace Oreste, Pisani Patrizia, Pardini Silvia, Bonora Danilo, Giorgetti Assuero, Gimelli Alessia, Neglia Danilo

机构信息

Imaging Department-Nuclear Medicine Unit, Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

CNR Institute of Clinical Physiology (IFC), Pisa, Italy.

出版信息

Eur Heart J Imaging Methods Pract. 2024 Jul 13;2(3):qyae070. doi: 10.1093/ehjimp/qyae070. eCollection 2024 Jul.

DOI:10.1093/ehjimp/qyae070
PMID:39224623
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11367967/
Abstract

Cardiometabolic risk factors, including high fasting plasma glucose (hFPG), are emerging prognostic determinants in patients with coronary artery disease (CAD) or heart failure (HF). Coronary microvascular dysfunction might be a comprehensive risk predictor in these patients. The purpose of this study was to assess whether hFPG and global myocardial blood flow (MBF) reserve measured by positron emission tomography (PET), expressing global coronary function, predict long-term prognosis beyond other risk factors and presence of obstructive CAD or left ventricular (LV) dysfunction associated with HF. We retrospectively collected long-term follow-up data in 103 patients (mean age 61 ± 10 years, 74 males) with stable chest pain or dyspnoea who underwent cardiac PET/computerized tomography and coronary angiography. Disease phenotypes included obstructive CAD (35%), LV dysfunction without obstructive CAD (43%), or none (22%). At multivariable logistic regression analysis, MBF reserve lower than the median value (OR 1.8, 95% CI 1.5-2.2) was significantly associated with male gender (OR 3.45, 95% CI 1.21-9.83) and hFPG (OR 3.87, 95% CI 1.17-12.84) among all risk factors. In a median follow-up of 10.9 years (interquartile range 7.8-13.9), 39 patients (37.8%) died (13.6% cardiac death). At multivariable Cox analyses including all risk factors and disease phenotypes, age (HR 1.07, 95% CI 1.02-1.12), hFPG (HR 2.18, 95% CI 1.02-4.63), and depressed MBF reserve (HR 4.47, 95% CI 1.96-10.18) were independent predictors of death (global 37.41, = 0.0004). These results suggest a strong long-term prognostic role of hFPG and depressed MBF reserve in a high-risk population of patients with a high prevalence of obstructive CAD or HF.

摘要

包括空腹血糖升高(hFPG)在内的心血管代谢危险因素,正成为冠状动脉疾病(CAD)或心力衰竭(HF)患者新的预后决定因素。冠状动脉微血管功能障碍可能是这些患者的综合风险预测指标。本研究的目的是评估hFPG和通过正电子发射断层扫描(PET)测量的整体心肌血流(MBF)储备(反映整体冠状动脉功能)是否能独立于其他危险因素以及与HF相关的阻塞性CAD或左心室(LV)功能障碍来预测长期预后。我们回顾性收集了103例(平均年龄61±10岁,男性74例)有稳定胸痛或呼吸困难症状的患者的长期随访数据,这些患者均接受了心脏PET/计算机断层扫描和冠状动脉造影。疾病表型包括阻塞性CAD(35%)、无阻塞性CAD的LV功能障碍(43%)或两者皆无(22%)。在多变量逻辑回归分析中,MBF储备低于中位数(比值比1.8,95%置信区间1.5 - 2.2)与所有危险因素中的男性性别(比值比3.45,95%置信区间1.21 - 9.83)和hFPG(比值比3.87,95%置信区间1.17 - 12.84)显著相关。在中位随访10.9年(四分位间距7.8 - 13.9年)期间,39例患者(37.8%)死亡(13.6%为心源性死亡)。在包括所有危险因素和疾病表型的多变量Cox分析中,年龄(风险比1.07,95%置信区间1.02 - 1.12)、hFPG(风险比2.18,95%置信区间1.02 - 4.63)和MBF储备降低(风险比4.47,95%置信区间1.96 - 10.18)是死亡的独立预测因素(整体χ² = 37.41,P = 0.0004)。这些结果表明,在阻塞性CAD或HF患病率较高的高危患者群体中,hFPG和MBF储备降低具有很强的长期预后作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ba8/11367967/ac493a1f55b2/qyae070f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ba8/11367967/ac493a1f55b2/qyae070f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ba8/11367967/ac493a1f55b2/qyae070f1.jpg

相似文献

1
Long-term prognostic impact of fasting plasma glucose and myocardial flow reserve beyond other risk factors and heart disease phenotypes.空腹血糖和心肌血流储备对长期预后的影响超过其他危险因素和心脏病表型。
Eur Heart J Imaging Methods Pract. 2024 Jul 13;2(3):qyae070. doi: 10.1093/ehjimp/qyae070. eCollection 2024 Jul.
2
Prognostic value of myocardial flow reserve vs corrected myocardial flow reserve in patients without obstructive coronary artery disease.无阻塞性冠状动脉疾病患者中心肌血流储备与校正心肌血流储备的预后价值。
J Nucl Cardiol. 2024 Jul;37:101854. doi: 10.1016/j.nuclcard.2024.101854. Epub 2024 Apr 7.
3
Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.用于评估心肌活力的正电子发射断层扫描:一项基于证据的分析。
Ont Health Technol Assess Ser. 2005;5(16):1-167. Epub 2005 Oct 1.
4
Integrated Noninvasive Physiological Assessment of Coronary Circulatory Function and Impact on Cardiovascular Mortality in Patients With Stable Coronary Artery Disease.稳定型冠状动脉疾病患者冠状动脉循环功能的综合无创生理评估及其对心血管死亡率的影响
Circulation. 2017 Dec 12;136(24):2325-2336. doi: 10.1161/CIRCULATIONAHA.117.029992. Epub 2017 Sep 1.
5
Prognostic implications of myocardial perfusion imaging by 82-rubidium positron emission tomography in male and female patients with angina and no perfusion defects.82 铷正电子发射断层扫描心肌灌注显像对有或无灌注缺损的心绞痛男性和女性患者的预后意义。
Eur Heart J Cardiovasc Imaging. 2023 Jan 23;24(2):212-222. doi: 10.1093/ehjci/jeac217.
6
Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction.射血分数保留的心力衰竭患者中的冠状动脉疾病和冠状动脉微血管功能障碍的患病率。
JAMA Cardiol. 2021 Oct 1;6(10):1130-1143. doi: 10.1001/jamacardio.2021.1825.
7
Impact of Absolute Myocardial Blood Flow Quantification on the Diagnostic Performance of PET-Based Perfusion Scans Using Rubidium.绝对心肌血流定量对基于放射性铷的 PET 灌注扫描诊断性能的影响
Circ Cardiovasc Imaging. 2024 Jan;17(1):e016138. doi: 10.1161/CIRCIMAGING.123.016138. Epub 2024 Jan 16.
8
Incremental prognostic value of digital positron emission tomography derived myocardial flow reserve: A prospective cohort study.数字正电子发射断层扫描衍生的心肌血流储备的增量预后价值:一项前瞻性队列研究。
Int J Cardiol. 2023 Jan 15;371:465-471. doi: 10.1016/j.ijcard.2022.09.015. Epub 2022 Sep 10.
9
Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health.心脏 PET 成像在冠状动脉疾病和微血管健康的检测和监测中的应用。
JACC Cardiovasc Imaging. 2010 Jun;3(6):623-40. doi: 10.1016/j.jcmg.2010.04.007.
10
PET-measured longitudinal flow gradient correlates with invasive fractional flow reserve in CAD patients.正电子发射断层扫描(PET)测量的纵向血流梯度与冠心病(CAD)患者的有创血流储备分数相关。
Eur Heart J Cardiovasc Imaging. 2017 May 1;18(5):538-548. doi: 10.1093/ehjci/jew116.

引用本文的文献

1
Cardiovascular imaging in 2024: review of current research and innovations.2024年心血管成像:当前研究与创新综述
Eur Heart J Imaging Methods Pract. 2025 May 17;3(1):qyaf066. doi: 10.1093/ehjimp/qyaf066. eCollection 2025 Jan.

本文引用的文献

1
Cardiovascular and Renal Benefits of Novel Diabetes Drugs by Baseline Cardiovascular Risk: A Systematic Review, Meta-analysis, and Meta-regression.新型糖尿病药物对心血管和肾脏的益处:基于基线心血管风险的系统评价、荟萃分析和荟萃回归。
Diabetes Care. 2023 Jun 1;46(6):1300-1310. doi: 10.2337/dc22-0772.
2
Myocardial Perfusion PET for the Detection and Reporting of Coronary Microvascular Dysfunction: A JACC: Cardiovascular Imaging Expert Panel Statement.用于检测和报告冠状动脉微血管功能障碍的心肌灌注正电子发射断层显像:美国心脏病学会杂志:心血管影像专家小组声明
JACC Cardiovasc Imaging. 2023 Apr;16(4):536-548. doi: 10.1016/j.jcmg.2022.12.015. Epub 2023 Feb 8.
3
Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association.
《心脏病与卒中统计数据-2023 更新:美国心脏协会报告》。
Circulation. 2023 Feb 21;147(8):e93-e621. doi: 10.1161/CIR.0000000000001123. Epub 2023 Jan 25.
4
The Global Burden of Cardiovascular Diseases and Risk: A Compass for Future Health.心血管疾病及其风险的全球负担:未来健康指南。
J Am Coll Cardiol. 2022 Dec 20;80(25):2361-2371. doi: 10.1016/j.jacc.2022.11.005. Epub 2022 Nov 9.
5
European Society of Cardiology: cardiovascular disease statistics 2021: Executive Summary.欧洲心脏病学会:2021 年心血管疾病统计数据:执行摘要。
Eur Heart J Qual Care Clin Outcomes. 2022 Jun 6;8(4):377-382. doi: 10.1093/ehjqcco/qcac014.
6
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2022年美国心脏协会/美国心脏病学会/美国心力衰竭学会心力衰竭管理指南:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
J Am Coll Cardiol. 2022 May 3;79(17):e263-e421. doi: 10.1016/j.jacc.2021.12.012. Epub 2022 Apr 1.
7
Coronary Microvascular Dysfunction Across the Spectrum of Cardiovascular Diseases: JACC State-of-the-Art Review.冠状动脉微血管功能障碍在心血管疾病谱中的表现:美国心脏病学会最新综述。
J Am Coll Cardiol. 2021 Sep 28;78(13):1352-1371. doi: 10.1016/j.jacc.2021.07.042.
8
Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options: JACC State-of-the-Art Review.冠状动脉微血管疾病的发病机制和治疗选择:美国心脏病学会最新综述。
J Am Coll Cardiol. 2018 Nov 27;72(21):2625-2641. doi: 10.1016/j.jacc.2018.09.042.
9
Structural abnormalities of the coronary arterial wall--in addition to luminal narrowing--affect myocardial blood flow reserve.冠状动脉壁的结构异常——除了管腔狭窄外——还会影响心肌血流储备。
J Nucl Med. 2011 Nov;52(11):1704-12. doi: 10.2967/jnumed.111.091009. Epub 2011 Sep 19.
10
Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction.心肌血流受损在特发性左心室功能障碍中的预后作用。
Circulation. 2002 Jan 15;105(2):186-93. doi: 10.1161/hc0202.102119.